Role of Chemotherapy and the Receptor Tyrosine Kinases KIT, PDGFRα, PDGFRβ, and Met in Large-Cell Neuroendocrine Carcinoma of the Lung

Giulio Rossi, Alberto Cavazza, Alessandro Marchioni, +12

Journal of Clinical Oncology

Mucinous Cells in Type 1 Pulmonary Congenital Cystic Adenomatoid Malformation as Mucinous Bronchioloalveolar Carcinoma Precursors

Sylvie Lantuéjoul, Andrew G. Nicholson, Giuliana Sartori, +6

The American Journal of Surgical Pathology

Type 1Cancer PathologyMucinous CellsEar MoldingPathology +10

Pleuro-pulmonary Solitary Fibrous Tumors

Laura Schirosi, Sylvie Lantuéjoul, Alberto Cavazza, +6

The American Journal of Surgical Pathology

Pleuro-pulmonary SftsMedicineSurgical PathologyImmunologyPathology +9

Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology

Giulio Rossi, Maria Cecilia Mengoli, Alberto Cavazza, +11

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Tumor BiologyMedicineMultiple Pulmonary NoduleMolecular BiologyPathology +7

A Single Institution-Based Retrospective Study of Surgically Treated Bronchioloalveolar Adenocarcinoma of the Lung: Clinicopathologic Analysis, Molecular Features, and Possible Pitfalls in Routine Practice

Christian Casali, Giulio Rossi, Alessandro Marchioni, +5

Journal of Thoracic Oncology

MedicinePossible PitfallsPathologyBronchial NeoplasmThoracic Surgery +8

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Carmelo Bengala, Stefania Bettelli, Federica Bertolini, +13

Annals of Oncology

Radiation TherapyMedicinePathologyColorectal CancerK-ras Mutation +3

Long Lasting Response to the Multikinase Inhibitor Bay 43-9006 (Sorafenib) in a Heavily Pretreated Metastatic Thymic Carcinoma

Giancarlo Bisagni, Giulio Rossi, Alberto Cavazza, +3

Journal of Thoracic Oncology

MedicineImmunologyPathologyImmune Checkpoint InhibitorCancer Treatment +3

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers

Marcello Tiseo, Giulio Rossi, Marzia Capelletti, +12

Lung Cancer

Prognostic BiomarkersGefitinib OutcomesMolecular MarkersMedicinePathology +7

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Laura Schirosi, Nazarena Nannini, D. Nicoli, +14

Annals of Oncology

Tumor BiologyC-kit MutationsDifferent C-kit InhibitorsOncogenic AgentMedicine +8

<i>EGFR</i> and K-<i>ras</i> Mutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors

Giuliana Sartori, Alberto Cavazza, Alessandro Sgambato, +11

American Journal of Clinical Pathology

Tumor BiologyPulmonary Epithelial TumorsMolecular Scoring SystemMedicineScoring System +12